Premium
Guselkumab for the treatment of plaque psoriasis
Author(s) -
Chaplin Steve
Publication year - 2018
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1682
Subject(s) - medicine , plaque psoriasis , psoriasis , dermatology , monoclonal antibody , monoclonal , immunology , antibody
Guselkumab (Tremfya) is a monoclonal antibody against interleukin‐23 for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. This article discusses its efficacy, side‐effects and place in therapy.